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Abstract 
Background: Malnutrition is common in hemodialysis patients and it 
must be controlled quickly. This study aimed to investigate the effect of 
zinc sulfate on malnutrition in dialysis patients. 
Methods: This study was a randomized controlled trial on 84 
hemodialysis patients referred to Imam Hossain hospital in Shahroud 
(northeastern of Iran). Patients were randomly divided into two case 
and control groups. For the intervention group, one tablet of zinc 
sulfate 220 mg was administered daily for 8 weeks. Both groups were 
subjected to standard dialysis three times in the week and all patients 
were assessed for malnutrition using a standard questionnaire, lab 
tests, and necessary examinations in the first stage, one month and two 
months after the treatment. 
Results: Of 84 patients, 39 cases (46.4%) were female and rest was 
male. The mean age of the patients was 59.1±27.2 years. The mean 
total duration of dialysis was 2.9±2.3 years. The severity and extent of 
malnutrition at the beginning and one month after the study did not 
differ between the two groups, but after the second month, there was a 
significant decrease of malnutrition in the intervention group 
(Pvalue=0.015). Also, malnutrition variables were significantly 
associated with BMI less than 18 kg/m2 (Pvalue<0.039), and serum 
creatinine less than 3 mg/dl (Pvalue<0.011) and hemoglobin less than 
11 g/dl (Pvalue<0.001), 
Conclusions: The results of this study showed that zinc sulfate 
consumption for at least 2 months could significantly reduce the 
severity of malnutrition in hemodialysis patients. 
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Introduction 
End=stage renal disease (ESRD) is one of the causes of 
mortality and disability worldwide.1 Hemodialysis is 
considered as the dominant treatment in many of these 
patients.2 Hemodialysis has a profound effect on individual and 
family life for various reasons3 and despite this method of 
treatment, it is a healthier and more patient's survival, but, it 
did not change the progressive of the disease and completely 
did not replace the function of the kidneys.4 In addition to 
observing the hemodialysis diet, limitation of fluids and 
medications are considered to be essential actions for the 
treatment of renal failure.5,6 One of the complex, multi-factorial 
and prevalent complications of hemodialysis in renal patients is 
energy–protein malnutrition which has a direct correlation with 
the mortality rate of these patients. Inappropriate food intake, 
anorexia, metabolic disorders, diseases and loss of protein, 
amino acids, and vitamins during dialysis and also the high rate 
of catabolism due to increased production of inflammatory 
cytokines, it can easily threaten the nutritional health of these 
patients.6 This will eventually intensify the loss of muscle 
tissue and fat stores that increases the vulnerability to various 
types of infections and diseases and increases disability and 
mortality.6,7 
According to studies in the United States, the number of 
patients with kidney failure is doubled every 7 years. The 
statistics in our country also show a dramatic increase in 
chronic renal failure, so that the total number of patients with 
dialysis in Iran during the first two months of the year of 1992 
was 3670, this figure was 8500 in 2002 and reached 28000 in 
2020.8 According to studies conducted in developing countries, 
42% of hemodialysis patients are malnourished. 
Anthropometric, biochemical and dietary indicators are among 
the nutritional indicators used in assessing the nutritional status 
of these patients which are more sensitive to intra-arm muscle 
(MAMC) and serum albumin levels.8-10 Zinc and iron 
deficiency is common in dialysis patients and is seen in most 
patients. Patients who undergo long-term dialysis are at 
increased risk for zinc deficiency.9 Zinc has an antioxidant that 
has anti-inflammatory properties and regulates immune 
response.4 Zinc deficiency in chronic kidney disease may be 
due to decreased bowel movements and absorption 
impairment.10 Zinc deficiency may be associated with 
symptoms of uremia, such as anorexia, loss of taste, sexual 
dysfunction, and reduced immune function.11 Better zinc levels 
are associated with reduced levels of inflammation, oxidative 
stress, dyslipidemia, and malnutrition in dialysis patients.12 
Adjusting the diet to meet nutritional needs and preventing and 
delaying undesirable side effects can greatly improve the 
quality and longevity of these patients.11-12 Regarding the high 
prevalence of dialysis patients in the community and the 
frequency of malnutrition rates in dialysis patients, this study 
aimed to investigate the effect of zinc sulfate on reducing 
malnutrition in patients undergoing dialysis in Shahroud. 
Materials and Methods 
This prospective triple-blind clinical trial was performed on 
84 patients with hemodialysis referred to Imam Hossain 
hospital, Shahroud, Iran from November 2017 to November 
2018 that randomly divided into two equal groups. 
Inclusion criteria were having a hemodialysis history over 6 
months; age over 15 years and under 65 years; no use of 
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supplemental medication in the last 4 weeks and no addiction 
to alcohol, smoking or drugs; satisfaction in research. 
Exclusion criteria were the presence of any uncontrolled 
malignancy; suffering too severe diseases such as heart, liver 
and gastrointestinal disease; chemotherapy; severe burns and 
dissatisfaction in research. 
Blinding description: In this study, patients, and the person 
responsible for drug distribution and analyzer it is blinded. All 
patients were examined for malnutrition before splitting into 
the intervention.  
The division of patients into two groups of intervention and 
control is done by a qualified nurse who does not know the 
actions performed in the two groups. Do malnutrition 
examination, drug therapy prescribing and results recorder will 
be done by a qualified nurse without any knowledge of the type 
of intervention and patients. In this study, eligible patients were 
selected by a simple census method to complete the sample 
size. Eligible patients were randomly divided into intervention 
and control groups with using quadric randomized blocks.  
For all patients suspected of malnutrition in both groups, a 
valid nutritional status questionnaire was used, that validity and 
reliability of which have been confirmed by various researchers, 
including Sosiototati, Ebrahim and Tirmantajin-Jankovic.13-15 
This questionnaire includes demographic and clinical 
information (age, sex, duration of dialysis and place of 
residence, blood tests (serum albumin, cholesterol, creatinine, 
hemoglobin, and dialysis adequacy) and specialized assessment 
of nutritional status. Nutrition status assessment (NSA) has 9 
items that was included personal information, underlying 
diseases, history of drug and food allergies, history of 
medication and nutritional supplements, nonmetric information 
(height, weight, BMI, arm circumference, normal weight, 
weight loss or weight gain, weight change time, digestive and 
eating problems (diarrhea, vomiting, nausea, constipation, 
swallowing, and chewing disorders), clinical condition (edema, 
ascites, muscle wasting, and skin and nail changes) and related 
laboratory tests. Each of these items had a score of one 
(minimum score) to 4 (maximum score). Therefore, the score 
of each person varied from 9 to 36 points. Therefore, based on 
the total scores of these 9 items, patients were divided into 
three groups: mild malnutrition (score 5 to 15), moderate 
malnutrition (score 16 to 25), and severe malnutrition (score 26 
to 36).  
Patients in the intervention group received zinc sulfate (one 
tablet of zinc sulfate 220 mg daily for 8 weeks). However, 
patients in the control group were treated with a placebo like 
intervention group. Both groups were subjected to standard 
hemodialysis three times in the week, according to standard 
and identical conditions.  
Measured patient-related variables were including age, sex, 
smoking, substance abuse and the duration of the hemodialysis 
and the variables associated with it was including the cause of 
dialysis, duration of dialysis, background diseases and 
malnutrition status and severity. Also was done required tests 
include: hemoglobin, creatinine, and BUN, URR rate, BMI, 
and arm circumference at the beginning of the study, 4 weeks 
and 8 weeks after treatment, and the malnutrition status was 
measured using an NSA questionnaire. All treatments were 
performed for patients in both groups for eight weeks. The flow 
diagram of the study is shown in figure 1. 
 
Figure 1 . The flow diagram of the study 
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Data analysis was performed based on intention to treat 
analysis by statistical software SPSS version 16. Sample size 
using Epi info 7.2 at a significant level of 5% and a power of 
80%, equal to 42 people in each group and a total of 84 people. 
For describing the findings, descriptive statistics such as 
mean±standard deviation and frequency were used. Due to the 
quantitative and qualitative variables, independent T and Chi-
square tests were used in the significance level of 0.05. 
This study has an ethics code number 
(IR.SHMU.REC.1396.63) from the ethics committee of 
Shahroud University of Medical Sciences and with code, 
IRCT2017102136703N2 on 8-11-2017 has been registered in 
Iranian clinical trials system. The essential information and the 
objectives of the study were explained to the patients, and 
written consent was obtained for participation in the plan. 
Results 
In this study, 45 (53.6%) of the participants were male and 
the rest were female. The mean age of all patients was 
59.3±27.9 years that was no significant difference between the 
two groups. The mean BMI of all patients was 24.1±3.5 kg/m2 
that was no significant difference between the two groups. The 
demographic, clinical, and laboratory data of the two groups 
are listed in table 1. Patients' severity of malnutrition showed 
that there was no significant difference between the two groups 
at the beginning of the study and one month after treatment 
with zinc sulfate, but in the second month of treatment, the 
severity of malnutrition was significantly lower in the 
intervention group (Pvalue<0.015). Table 2 shows the 
malnutrition status of patients in the two groups at different 
times. In this study, independent variables with malnutrition 
were investigated in the multivariate regression model. As was 
shown in table 3, malnutrition variables were significantly 
associated with BMI less than 18 kg/m2 (Pvalue<0.039), and 
serum creatinine less than 3 mg/dl (Pvalue<0.011) and 
hemoglobin less than 11 g/dl (Pvalue<0.001), and there was no 
significant relationship with other variables. The results of the 
multivariate logistic regression model are presented in table 3. 
Table 1. The demographic, clinical and lab information of patients in beginning of study 
Demographic & clinical information 
Intervention group 
Mean±SD/Number (%) 
Control group 
Mean±SD/Number (%) 
Total 
Mean±SD/Number (%) 
Pvalue 
Age (year) 59.3±27.9 58.9±27.3 59.1±27.3 0.088 
Age category 
 <20 years 
 20-40 years 
 40-60 years 
 >60 years 
 
0(0.0) 
8(19.1) 
23(54.7) 
11(26.2) 
 
0(0.0) 
6(14.3) 
24(57.1) 
12(28.6) 
 
0(0.0) 
14(16.7) 
47(55.9) 
23(27.4) 
 
 
0.125 
Sex 
 Male 
 Female 
 
23(54.7) 
19(45.3) 
 
22(52.4) 
20(47.6) 
 
45(53.8) 
39(46.2) 
 
0.059 
BMI (kg/m2) 24.3±3.5 23.9±3.4 24.1±3.5 0.213 
Duration of dialysis (year)  3.1±2.4 2.8±2.3 2.9±2.4 0.109 
Arm circumference (cm) 32.6±4.2 31.9±4.3 31.2±4.2 0.097 
Serum creatinine (mg/dl) 2.7±3.8 2.4±3.5 2.5±3.6 0.103 
BUN (mg/dl) 67.4±25.6 65.9±26.4 66.3±25.9 0.091 
Hemoglobin (g/dl) 9.7±1.9 10.1±2.1 9.9±1.9 0.184 
URR* (%) 59.5±3.5 58.6±4.3 58.9±3.9 0.089 
 
 
Table 2. Frequency distribution of patients in two groups based on severity of malnutrition 
Severity of malnutrition at different times 
Intervention group 
Number (%) 
Control group 
Number (%) 
Total 
Number (%) 
Pvalue 
Beginning of study 
 Mild malnutrition 
 Moderate malnutrition 
 Severe malnutrition 
 
7(16.7) 
24(57.1) 
11(26.2) 
 
9(21.4) 
23(54.8) 
10(23.8) 
 
16(19.1) 
47(55.9) 
21(25.0) 
 
0.117 
1 Mount after intervention 
 Mild malnutrition 
 Moderate malnutrition 
 Severe malnutrition 
 
12(28.6) 
23(54.8) 
7(16.7) 
 
10(23.8) 
24(57.1) 
8(19.1) 
 
22(26.2) 
47(55.9) 
15(17.9) 
 
0.055 
2 Mount after intervention 
 Mild malnutrition 
 Moderate malnutrition 
 Severe malnutrition 
 
21(50.0) 
17(40.5) 
4(9.6) 
 
10(23.8) 
26(61.9) 
6(14.3) 
 
31(36.9) 
43(51.2) 
10(11.9) 
 
0.015 
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Table 3. Relationship between independent variables with malnutrition in multivariate logistic regression model 
Independent variables Odds Ratio 95% Confidence Pvalue 
Age category (year)    
 >20 
 20 to 40 
 40 to 60 
 <60 
1.000 
1.016 
1.077 
1.161 
 
1.142-0.0852 
1.238-0.0881 
1.351-0.0912 
 
0.093 
0.075 
0.053 
Sex    
 Male 
 Female 
1.000 
1.125 
 
1.213-0.815 
 
0.069 
Body mass index (kg/m2)    
 18-25 
 <18 
 >25 
1.000 
1.723 
0.881 
 
1.985-1.456 
1.105-0.612 
 
0.039 
0.085 
Duration of dialysis (year)    
 <1 
 1-3 
 >3 
1.000 
1.151 
1.182 
 
1.323-0.871 
1.388-0.927 
 
0.103 
0.079 
Arm circumference (cm)    
 >35 
 <35 
1.000 
1.296 
 
1.542-1.109 
 
0.052 
Serum creatinine (mg/dl)     
 <3 
 >3 
1.000 
1.489 
 
1.763-1.216 
 
0.011 
BUN (mg/dl)     
 <40 
 >40 
1.000 
1.028 
 
1.282-0.857 
 
0.079 
Hemoglobin (g/dl)     
 <11 
 >11 
1.000 
1.551 
 
1.854-1.256 
 
0.001 
URR (%)    
 >60 
 <60 
1.000 
1.081 
 
1.218-0.855 
 
0.068 
 
Discussion 
The results of this study showed that zinc sulfate 
consumption for at least 2 months could significantly reduce 
the severity of malnutrition in dialysis patients. It was also 
found that factors like BMI of less than 18kg/m2, creatinine 
less than 3mg/dl and hemoglobin below 11g/dl could 
significantly increase the severity of malnutrition. Malnutrition 
is a common finding in hemodialysis patients and its symptoms 
are observed in more than 35% of these patients.16 The severity 
of malnutrition in these patients varies from mild to very 
severe.17 According to the results of several studies, there is no 
single method for assessing the nutritional status of 
hemodialysis patients and most scholars have emphasized with 
a combination of existing methods, including the study of the 
clinical history of weight loss, dietary evaluation and 
anthropometric indexes, biochemical parameters, evaluation of 
impedance analysis, and etc. In this study, a measure of 
malnutrition evaluation in hemodialysis patients was a 
combination of cases that were evaluated in the form of a 
questionnaire, clinical examinations, and laboratory tests.18,19 
The results of this study showed that all patients at the 
beginning of the study had a degree of malnutrition. This 
finding is similar to the results of El-Shazly, Roozbeh and 
Matson studies which states that the prevalence of malnutrition 
in dialysis patients is between 85% and 95%, consistency hip-
and-thigh.20-22 One of the reasons for inadequate intake and 
anorexia in these patients can be pointed out, is the presence of 
inflammation and infection, gastrointestinal upset, feeling weak 
and post-dialysis fatigue, nausea, depression, and medication.23 
The results of this study showed that the use of zinc sulfate 
supplementation could significantly reduce the severity of 
malnutrition among hemodialysis patients. However, zinc 
sulfate should be continued for at least two months in these 
patients. This result is fully consistent with the results of Lok 
and Chevalier but is relatively consistent with Jerne’s study, 
which found that one month of zinc sulfate treatment was 
sufficient to reduce malnutrition.24-26 
The middle of the arm circumference (MAC) represents the 
skeletal, skeletal, and subcutaneous fat muscles, and is a rough 
estimate of the body's fat and protein reserves. It is also used as 
a rapid method to assess the status of long-term nutritional 
intervention.27,28 
Middle arm muscle circumference (MAMC) is a quick way 
to calculate the estimated amount of muscle mass, and values 
below 5 percent or above 95 percent indicate some type of 
nutritional risk.29 In this study, subcutaneous fat was used to 
measure malnutrition, assuming that in various studies, the 
index of adipose tissue in the area of the triceps muscle shows 
the total body fat reserves and the fat thickness at this location 
indicates the average thickness of the total subcutaneous 
reserves. The measurement of this part can be very accurate.30 
In many studies, BMI has been used to assess malnutrition. 
In the present study, BMI was used but no significant 
difference was observed between the two groups regarding this 
criterion and the finding is similar to the Morais study but 
differs from the Ashabi study, perhaps the reason for this 
difference is related to the sample size and different sex 
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composition of the two studies or the difference in the duration 
of dialysis of patients in the two groups.31,32 
In many studies, blood albumin levels have been identified 
as a common indicator in the nutritional assessment of patients, 
and a dose of less than 3.5 g/dl has been shown to indicate 
protein-energy malnutrition.33,34 However, in the present study, 
for various reasons, such as technical problems in the 
laboratory of Imam Hossain hospital and the lack of 
cooperation of patients to collect urine albumin in 24 hours, 
this test was not used to assess malnutrition. 
Creatinine is derived from the non-enzymatic metabolism 
of skeletal muscle. Low serum creatinine levels indicate 
nutritional disorders in these patients that will be associated 
with increased mortality.35 In this study, about half of the 
patients had lower creatinine than normal at the start of the 
study, indicating severe malnutrition but, with use of zinc 
sulfate significantly increased the creatinine content of these 
patients, which indicated an improvement in their malnutrition, 
which is consistent with the results of Pupim and Kalantar-
Zadeh studies.36,37 
The results of this study showed that the use of zinc sulfate, 
reduces the severity of malnutrition in dialysis patients, but it 
needs to be used regularly for at least two months. But in order 
to fully confirm this, more research is needed with larger 
sample size. Therefore, all patients with malnutrition 
hemodialysis should be screened for vitamin deficiencies, 
especially zinc sulfate, and corrected as soon as possible if such 
defects are identified. 
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